CELCC 2014 Abstracts
O11. The results of gefitinib in front line treatment of Caucasian patients with NSCLC in the Czech Republic: analysis according to activated mutations location
Jana Skrickova, Zbynek Bortlicek, Karel Hejduk, Milos Pesek, Vitezslav Kolek, Leona Koubkova, Marcela Tomiskova, Jaromir Roubec, Libor Havel, Frantisek Salajka
